You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 8,159,661


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,159,661
Title:Hyper-spectral imaging and analysis of a sample of matter, and preparing a test solution or suspension therefrom
Abstract: Method for hyper-spectral imaging and analysis of a sample of matter, for identifying and characterizing an object of interest therein. Preparing test solution or suspension of the sample, including adding thereto a spectral marker specific to object of interest, such that if object of interest is in test solution or suspension, object of interest becomes a hyper-spectrally active target which is hyper spectrally detectable and identifiable; adding to test solution or suspension a background reducing chemical, for reducing background interfering effects caused by presence of objects of non-interest in test solution or suspension, thereby increasing hyper spectral detectability of hyper spectrally active target in test solution or suspension; generating and collecting hyper-spectral image data and information of test solution or suspension; and, processing and analyzing thereof. Exemplary objects of interest are biological agents--bacteria (Bacillus anthracis), viruses, fungi, toxins, or, chemical agents--nerve agents (sarin, tabun, soman), and chemical poisons.
Inventor(s): S. Moshe; Danny (Kiryat Ono, IL), Weinstein; Vladimir (Rishon-Lezion, IL)
Assignee: Green Vision Systems Ltd. (Tel-Aviv, IL)
Application Number:12/527,206
Patent Claims:1. A method for hyper-spectral imaging and analysis of a sample of matter, for identifying and characterizing an object of interest therein, the method comprising: preparing a test solution or suspension of the sample of matter, said preparing includes adding to the sample of matter a spectral marker specific to the object of interest, such that if the object of interest is present in said test solution or suspension, the object of interest when marked with said spectral marker becomes a hyper-spectrally active target which is hyper-spectrally detectable and identifiable in said test solution or suspension; generating and collecting hyper-spectral image data and information of said test solution or suspension; and processing and analyzing said hyper-spectral image data and information, for identifying and characterizing said hyper-spectrally active target in said test solution or suspension, thereby identifying and characterizing the object of interest in the sample of matter; wherein said preparing said test solution or suspension includes adding to said test solution or suspension a background reducing chemical, wherein said background reducing chemical reduces background interfering effects caused by presence of objects of non-interest in said test solution or suspension, during the hyper-spectral imaging and analysis, thereby increasing hyper-spectral detectability of said hyper-spectrally active target in said test solution or suspension.

2. The method of claim 1, wherein the sample of matter is a sample of air.

3. The method of claim 1, wherein the object of interest is a biological agent or a chemical agent.

4. The method of claim 3, wherein said biological agent is selected from the group consisting of a bacterium, a virus, a fungus, and a toxin.

5. The method of claim 4, wherein said bacterium is spore-forming bacterium Bacillus anthracis.

6. The method of claim 3, wherein said chemical agent is selected from the group consisting of a nerve agent, and a chemical poison.

7. The method of claim 1, wherein said spectral marker specific to the object of interest is selected from the group consisting of chemical markers and biological markers.

8. The method of claim 7, wherein said chemical marker is terbium trichloride [TbCl.sub.3].

9. The method of claim 7, wherein said biological marker is an antibody of an immunoassay technique.

10. The method of claim 1, wherein said background reducing chemical is selected from the group consisting of solids, and liquids.

11. The method of claim 10, wherein said liquid is an organic liquid.

12. The method of claim 11, wherein said organic liquid is ethylene glycol (monoethylene glycol (MEG) or ethane-1,2-diol) [HOCH.sub.2CH.sub.2OH].

13. The method of claim 1, wherein said processing and analyzing said hyper-spectral image data and information includes evaluating a detectability level of said hyper-spectrally active target in said test solution or suspension according to three criteria: (1) area of all positive pixels in a hyper-spectral image expressing characteristic spectral finger prints of light emitted by said hyper-spectrally active target, (2) fluorescence intensity of every said positive pixel in said hyper-spectral image that expresses said characteristic spectral finger prints of said hyper-spectrally active target, and (3) relationship between said characteristic spectral finger prints included in said positive pixels of said hyper-spectral image and of a hyper-spectral image database.

14. The method of claim 13, further including analyzing said hyper-spectral image for said characteristic spectral finger prints at a one pixel resolution, and calculating total said area that subtends all said positive pixels for each said hyper-spectral image and concentration of said spectral marker.

15. The method of claim 13, further including calculating minimum, maximum, and average intensities of a spectral region around a characteristic emission peak of said hyper-spectrally active target.

16. The method of claim 13, further including creating two distinct data bases, wherein a first data base corresponds to all available spectra of said background interfering effects, and a second data base includes all spectra corresponding to said hyper-spectrally active target.

17. The method of claim 16, further including comparing spectral finger prints incorporated in said positive pixels of said hyper-spectral image to spectral finger prints from said two distinct data bases, whereby said positive pixels are divided into said hyper-spectrally active target and said background interfering effects, and then correlating, for yielding percentage of said positive pixels corresponding to said hyper-spectrally active target and percentage of said positive pixels corresponding to said background interfering effects.

18. The method of claim 17, wherein said percentages of positive pixels are used in a bar graph for showing distribution of said characteristic spectral finger prints of said hyper-spectrally active target and of said background interfering effects among said positive pixels of said hyper-spectrally active target, as a function of a count of the object of interest.

19. A method for preparing a test solution or suspension from a sample of matter, the test solution or suspension being particularly suitable for subjecting to hyper-spectral imaging and analysis, the method comprising: preparing a solution or suspension of the sample of matter, said preparing includes adding to the sample of matter a spectral marker specific to an object of interest, such that if said object of interest is present in the test solution or suspension, said object of interest when marked with said spectral marker becomes a hyper-spectrally active target which is hyper-spectrally detectable and identifiable in the test solution or suspension; wherein said preparing said solution or suspension includes adding to said solution or suspension a background reducing chemical, thereby forming the test solution or suspension, wherein said background reducing chemical reduces background interfering effects caused by presence of objects of non-interest in the test solution or suspension, during hyper-spectral imaging and analysis of the test solution or suspension, thereby increasing hyper-spectral detectability of said hyper-spectrally active target in the test solution or suspension.

20. The method of claim 19, wherein the sample of matter is a sample of air.

21. The method of claim 19, wherein said object of interest is a biological agent or a chemical agent.

22. The method of claim 21, wherein said biological agent is selected from the group consisting of a bacterium, a virus, a fungus, and a toxin.

23. The method of claim 22, wherein said bacterium is spore-forming bacterium Bacillus anthracis.

24. The method of claim 21, wherein said chemical agent is selected from the group consisting of a nerve agent, and a chemical poison.

25. The method of claim 19, wherein said spectral marker specific to the object of interest is selected from the group consisting of chemical markers and biological markers.

26. The method of claim 25, wherein said chemical marker is terbium trichloride [TbCl.sub.3].

27. The method of claim 25, wherein said biological marker is an antibody of an immunoassay technique.

28. The method of claim 19, wherein said background reducing chemical is selected from the group consisting of solids, and liquids.

29. The method of claim 28, wherein said liquid is an organic liquid.

30. The method of claim 29, wherein said organic liquid is ethylene glycol (monoethylene glycol (MEG) or ethane-1,2-diol) [HOCH.sub.2CH.sub.2OH].

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.